Preventing Youth Violence Through Building Equitable Communities
Launched by UNIVERSITY OF SOUTH ALABAMA · Nov 25, 2022
Trial Information
Current as of August 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Violence disproportionately affects African American youth. In addition to death and injury, violence exposure has significant psychological consequences, including traumatic stress symptoms and internalizing problems. Self-directed violence has shown startling and disproportionate growth among African American youth, with suicide rates nearly doubling from 2007 to 2018. Current prevention strategies have limited effectiveness, perhaps due to their failure to address the causal role of structural racism in violence. The primary aim of this proposed project is to examine the extent to which ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Youth will be eligible for the study if they attend a participating school, are capable of providing assent, and are able to understand spoken or written English.
- • School personnel will be eligible if they are currently employed at a participating school.
- Exclusion Criteria:
- • Unable to give assent or consent.
About University Of South Alabama
The University of South Alabama is a leading academic institution dedicated to advancing healthcare through innovative research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical fields to facilitate groundbreaking studies that aim to improve patient outcomes. With a commitment to ethical standards and rigorous scientific methodologies, the University of South Alabama fosters collaboration among researchers, healthcare professionals, and community partners to address pressing health challenges and contribute to the body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mobile, Alabama, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials